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Abstract
Background: Clinacanthus nutans is used traditionally in many parts of Asia to improve well-being, but there are
limited studies on its efficacy. We explored the potential use of C. nutans for prevention of high fat and high
cholesterol diet-(HFHC-) induced insulin resistance in rats.
Methods: The leaf of C. nutans was extracted using water (AL extract) and methanol (AML extract), and the extracts
were fed to rats alongside the HFHC diet for 7 weeks, and compared with simvastatin. Oral glucose tolerance test,
and serum insulin, retinol binding protein 4 (RBP4), adiponectin and leptin were measured. Homeostatic model
assessment of insulin resistance (HOMA-IR) was computed, while transcriptional regulation of hepatic insulin
signaling genes was also assessed.
Results: Glycemic response was higher in the HFHC group compared with the AL and AML groups, which also
had lower serum RBP4, fasting glucose, insulin and HOMA-IR. Serum adiponectin levels were higher, while leptin
levels were lower in the AML and AL groups compared to the HFHC group. There was upregulation of the Insulin
receptor substrate, phosphotidyl inositol-3-phosphate, adiponectin receptor and leptin recetor genes, in comparison
with the HFHC group.
Conclusions: Overall, the results showed that the HFHC diet worsened metabolic indices and induced insulin
resistance partly through transcriptional regulation of the insulin signaling genes. C.nutans, on the other hand,
attenuated the metabolic effects and transcriptional changes induced by the HFHC diet. The results suggested that
C.nutans may be a good source of functional ingredient for the prevention of insulin resistance.
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Background
Hyperlipidemia is a common predicament in many soci-
eties due to changing lifestyle and food practices [1].
Previous studies have shown that the uncontrolled con-
sumption of high fat and high cholesterol (HFHC) diet
leads to insulin resistance [2, 3]. The resistance to the
action of insulin can result from a variety of causes,
including defects both in the receptor binding and at the
post receptor levels [4]. In insulin signaling pathways,
the binding of insulin to its receptor activates a series of
cascade involving insulin receptor substrate (IRS) and
phosphatidylinositol 3-kinase (PI3K), which are critical
in insulin signaling and action [5]. One characteristic of
the HFHC diet is that it causes enlargement of adipose
tissue, which is a major secretory and endocrine organ,
whose secreted proteins play physiological roles in me-
tabolism. Accordingly, leptin, retinol binding protein 4
(RBP4), adiponectin and several other adipocytokines
are reported to play a role in the regulation of insulin
resistance and lipid metabolism [6]. Long term insulin re-
sistance leads to increases in the risks of cardiovascular
disease, diabetes mellitus and its associated complications
such as diabetic nephropathy, retinopathy, neuropathy
and cardiovascular disease [7].
Several pharmacological agents have been used to treat
insulin resistance; however, these pharmacological agents
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cause significant side effects [8]. Studies have shown that
natural products could offer similar or even better
effects with lesser side effects [9]. C.nutans (Burm. f.)
Lindau, commonly called Sabah Snake Grass or Belalai
Gajah, is widely used in Malaysia, Thailand and
Indonesia as traditional medicine and is categorized as
an essential medicinal plant for primary health care by
the Thai Ministry of Public Health, National Drug, and
Committee [10]. C.nutans is reported to possess various
medicinal properties including blood glucose lowering
effect, alpha-glucosidase inhibition activity, antioxidant
activities, anti-cancer properties and anti-inflammatory
effects [11–15]. Moreover, this herb has been used trad-
itionally to control diabetes, lower cholesterol and man-
age cancer. However, there is lack of scientific evidence
regarding its effects. Thus, in this study, its effects on
HFHC-induced insulin resistance were evaluated. Accord-
ingly, the insulin resistance biomarkers such as serum
insulin, leptin, adiponectin, retinol binding protein 4
(RBP4) and lipid profile were assayed, and the underlying
transcriptomic changes induced by C.nutans on hepatic
insulin resistance-related genes were evaluated. Further-
more, chromatographic analysis of the bioactives present
in the extracts was also conducted.
Methods
Reagents and chemicals
General chemicals were purchased from either Sigma-
Aldrich Chemical (USA) or Thermo Fisher Scientific
(Massachusetts, USA). All the chemicals used in this
study were of analytical reagent grade including metha-
nol, acetic acid, acetonitrile, petroleum ether and phos-
phoric acid. Phenolic acid standards (Vanillic, proto-
Catechuic acid, Cinnamic acid, Chlorogenic, Gallic, Caf-
feic and p-Coumaric) were purchashed from Sigma Al-
drich Chemical (USA). Genome LabGeXP Start Kit was
obtained from Beckman Coulter Inc. (USA), and the
RNA isolation kit (GF-TR-100 RNA Isolation Kit) was
purchased from Vivantis (Selangor, Malaysia). RCL 2 was
purchased from Alphelys (Toulouse, France) and MgCl2
as well as DNA Taq polymerase were purchased from
Thermo Fisher Scientific (Pittsburgh, PA). The fine
sugar and starch powders used to make pellets were
purchased from R & S Marketing Sdn. Bhd. (Malaysia),
and the Palm Oil, Nespray fortified milk powder, and
standard rat chow were purchased from Unilever
(Malaysia), Nestle Manufacturing (Malaysia), and Spe-
cialty Feeds (TN, USA), respectively
Collection of plant materials and sample preparation
C.nutans was collected on February, 2012 from YPL
Herbal Farm, Taipei, Seremban, Negeri Sembilan,
Malaysia. Authentication was made by the botanist at the
Herbarium of Biodiversity Unit, Institute of Bioscience,
Universiti Putra Malaysia where the voucher specimen
was deposited SK 2002/12.
Proximate and mineral analyses of C. nutans leaf
The moisture content was determined using the official
method of Association of Official Analytical Chemists
[16]. A convection oven was used to dry the samples
until constant weight was obtained, and the moisture
content was calculated as follows:
Percent of moisture ¼ ½1− ðweight of dry sample
= weight of wet sampleÞ  100:
Furthermore, the determination of lipid content was
performed following Soxtec method using Soxtec™ 2050
automated Analyzer (FOSS Analytical, Denmark), based
on the official method of Association of Official Analyt-
ical Chemists [16]. Petroleum ether was used for the
extraction and the fat content was obtained following
the equation:
Percent of fat ¼ Weight cup þ residueð Þ
– Weight cupð ÞÞ = weight sampleð Þð 
 100x
Where,
Weight (cup + residue) = Weight of extraction cup and
residue (g)
Weight (cup) = Weight of the extraction cup (g)
Weight (sample) = Weight of sample (g)
The total nitrogen content in the sample was deter-
mined following the official method of the Association
of Official Analytical Chemists [16]. The total nitrogen
content was determined using Kjeltec™ 2200 Auto Distil-
lation Unit (FOSS Tecator, Sweden). A nitrogen-to-
protein conversion factor of 4.4 was used in the deter-
mination of protein present in the samples.
A dry ashing method was used to determine the ash
content [16]. The samples were incinerated in a furnace
(Furnace 62700, Barnstead/Thermolyne, IA, and USA)
set at 550 °C. The remaining inorganic material was
cooled, weighed and further used for the determination
of mineral contents. An ash solution was prepared by
dissolving the ash in 100 ml of 1 M HCl. The contents
of sodium, potassium, calcium, and copper were then
measured using the flame system of the Atomic Absorp-
tion Spectrophotometer (AA400, Analytik Jena AG, Jena,
Germany). The results for mineral content were
expressed as mg/100 g dry weight (DW).
The total carbohydrate content (%) in the samples was
calculated by difference. The caloric value was calculated
by the sum of the percentages of proteins and carbohy-
drates multiplied by a factor of 4 (Kcal/g) and total lipids
multiplied by a factor of 9 (Kcal/g).
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Solvent extraction
The leaf of C. nutans was pulverised into fine powder
using a stainless steel blender (Waring Commercial, Tor-
rington, CT, USA) and passed through a mesh opening of
35 mm sieve. The leaf and solvent mixtures [water and
aqueous methanol (80 % Methanol)] were sonicated for 60
min at 25 °C in an ultrasound water bath (Power sonic
505, Hwa Shin Technology Co., Seoul, Korea). The mix-
tures were then individually filtered through Whatman fil-
ter paper No. 1 and the entire extraction process was
repeated twice on the residue obtained from the previous
filtration process. Subsequently, solvents were removed
under reduced pressure (Rotavapor R210, Buchi, Postfach,
Flawil, Switzerland) followed by lyophilization (Virtis
Benchtop K Freeze Dryer, SP Industries, War-Minster, PA,
USA). Then, the extracts yield were calculated prior kept
in - 80 °C for further analysis.
Experimental animals
Healthy male Sprague–Dawley rats weighing about 200
g-250 g were used for the study. The animals were
housed in large spacious cages. Food and water were
given ad libitum. The animal house was well ventilated
and under a 12 h light/dark cycle at the ambient
temperature of 25-30 °C, throughout the experimental
period. Rats were allowed to adapt to their environmen-
tal conditions for at least 10 days before the initiation of
experiment. All experiments and protocols described in
the study were approved by the Animal Ethics Commit-
tee (Project approval number: UPM/FPSK/PADS/BR-
UUH/00484) of the Faculty of Medicine and Health Sci-
ence, Universiti Putra Malaysia, Malaysia.
Diet preparation
The HFHC diet was formulated according to Imam et
al. [17], with minor modifications. Every kg of the
HFHC formulation contained 500 g ground standard
rat chow, 25 g of cholesterol, 200 ml palm oil, 60 g fine
sugar, 200 g Nespray® full cream milk and 50 g of starch
(See Additional file 1 for diet composition). This HFHC
pellet was dried in an incubator at 60 °C for 24 h, cut
into small equal sized pieces and fed to the rats.
The rats were randomly divided into nine groups of
seven rats each; the normal control (NC) received nor-
mal pellet, while the control group received HFHC and
the STATIN groups received HFHC + oral gavage of 10
mg/kg/day simvastatin. The aqueous leaf extract (AL)
and aqueous methanolic leaf extract (AML) groups were
given HFHC + oral gavage of 500, 250 or 125 mg/kg/
day/rat of the respective extracts.
Body weights, tissue collection and blood sampling
During the experiment, weekly body weights of the rats
were recorded, while at the end of the experimental
period (7 weeks), the animals were fasted overnight and
sacrificed by dissection method. Blood (10 ml) was col-
lected by venous puncture after an overnight fast, and
centrifuged at 3000 rpm for 10 min at 4 °C to separate
the serum. The serum was transferred into 1.5 ml tubes
(eppendoff ) and stored at −20 °C until analysis. The
liver, kidney, heart, brain, spleen and lungs were excised
immediately, washed with ice-cold saline, dried with fil-
ter paper, and then weighted prior to storage in
formalin-free tissue fixation, RCL2 at −80 °C.
Insulin resistance biomarkers
Oral glucose tolerance test (OGTT)
At the end of the intervention, OGTT was performed as
described by Matsuda & DeFronzo [18] on each animal
after an overnight fast, and measurements were taken with
a glucometer (Roche Diagnostics, Indianapolis, IN, USA).
Serum insulin, glucose and homeostatic model of insulin
resistance (HOMA-IR)
Serum from blood collected in plain tubes was used for
measurements of insulin using the ELISA kit according
to the manufacturers’ instructions. The absorbance were
read on a micro plate reader (BioTeK Synergy H1
Hybrid Reader, BioTek Instruments Inc., Winooski, VT,
USA) and results calculated from the standard curves; y =
0.762x – 0.143, R2 = 0.966. In addition, insulin resistance
(IR) was assessed by the HOMA-IR, a mathematical
model describing the degree of IR from fasting plasma
glucose and insulin, as described previously [3].
Serum RBP4, adiponectin and leptin levels
Serum from blood collected in plain tubes was used for
measurements of RBP4, adiponectin, and leptin using the
respective ELISA kits according to the manufacturers’
instructions. Absorbances were read on BioTeK Synergy
H1 Hybrid Reader (BioTek Instruments Inc., Winooski,
VT, USA) at 450. The results were analyzed on
www.myassays.com using four parametric test curve;
adiponectin (R2 = 0.9954), RBP4 (R2 = 9969), leptin (R2
= 0.9916).
Hepatic mRNA expression level
Hepatic RNA was isolated using the GF-TR-100 RNA
Isolation Kit (Vivantis, Malaysia) according to the kit
protocol, and primers were designed in the GenomeLa-
beXpress Profiler software using Rattus norvegicus
sequence adopted from the National Center for Bio-
technology Information GenBank Database (http://
www.ncbi.nlm.nih.gov/nucleotide/). Genes of interest,
housekeeping genes and an internal control are shown
in Table 1. The forward and reverse primers had uni-
versal sequences (tags) in addition to nucleotides that
were complementary to the target genes. Primers were
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supplied by First Base Ltd. (Selangor, Malaysia), and
diluted in 1× Tris-EDTA buffer to a final concentration
of 500 nM for reverse primer and 200 nM for forward
primers. Then, reverse transcription and multiplex PCR
of RNA samples (50 ng each) were done in an XP Ther-
mal Cycler (BIOER Technology, Hangzhou, China)
according to the kit protocol, while PCR products (1 μL
each) from the above reactions were mixed with 38.5
μL of sample loading solution and 0.5 μL of DNA size
standard 400 (Beckman Coulter, Inc, Miami, FL, USA)
in a 96-well sample loading plate and analyzed in the
GeXP machine (Beckman Coulter, Inc, Miami, FL,
USA). The results from the machine were analyzed using
the Fragment Analysis module of the GeXP system soft-
ware and then imported into the analysis module of
eXpress Profiler software. Normalization was done with
GAPDH.
Analysis of selected phenolic compounds by HPLC-DAD
HPLC-DAD analysis was performed to identify and
quantify major phenolic compounds in the leaf extracts
of C. nutans; aqueous leaf (AL) and aqueous methanol
leaf (AML) extracts. Samples were injected using an Agi-
lent G1310A auto-sampler into an Agilent 1200 series
HPLC linked with DAD 1300 diode array detector (Agi-
lent, Stevens Creek Blvd Santa Clara, USA). Chromato-
graphic separations were performed on a LUNA C-18
column (5 mm, 250 x 4.6 mm) (Phenomenex, Torrance,
CA, USA). The solvent composition and gradient elution
conditions were described previously by Chan et al. [19].
The mobile phase was composed of solvent (A) water–
acetic acid (94:6 v/v, pH 2.27) and solvent (B) aceto-
nitrile. The solvent gradient was as follows: 0–15 % B in
40 min, 15–45 % B in 40 min and 45–100 % B in 10
min. A flow rate of 0.5 ml/min was used and 20 μl of
sample were injected. Samples and mobile phases were
filtered through a 0.22 μm Millipore filter, type GV
(Millipore, Bedford, MA) prior to HPLC injection. The
standards used were Ferulic acid, PCA, Gallic acid, p-
Coumaric, Chlorogenic acid, Vanillic acid and Caffeic
acid, at the concentration of 0.1 mg/ml measured at 320
nm. The samples were analysed in triplicate and results
were expressed as micrograms per gram (mg/g) of
extract.
Statistical analysis
The values were expressed as mean ± SD (n = 7) in each
group. Differences between each group were assessed by
one way analysis of variance (ANOVA) using SPSS 17
version with post hoc comparisons (according to Duncan’s
multiple range test ). P < 0.05 was considered significant.
Results
Proximate analysis and mineral content
The mean values for the proximate analysis of the leaf of
C. nutans are shown in Table 2. The major nutrient was
crude carbohydrate (73.27 ± 3.14 % DW). The crude pro-
tein in the leaf was 5.16 ± 0.08 % DW, while the fat con-
tent was the lowest (2.21 ± 0.66 % DW), and the moisture
content was 9.28 ± 0.40 % DW. The minerals present in
the leaf are shown in Table 2. Potassium (K) was the most
abundant followed by Calcium (Ca), Sodium (Na) and
Copper (Cu).
C. nutans extracts slowed the rate of weight gain induced
by HFHC diet
Figure 1 shows the body weight changes throughout the
experimental period. There was significant increase in body
weight of the HFHC group in comparison with the NC
group (p < 0.05). There were significant decreases in body
weights of the treated groups starting from week 4, in
comparison with the HFHC group (p < 0.05). Generally, C.
nutans slowed the rate of weight gain dose-dependently,
and by the end of the intervention period, all the treated
groups had lower weights than the HFHC group.
Table 1 Names, accession number and primer sequences used in the study
Gene name Primer sequence(with universal tag)
Forward primer Reverse primer
AdiponectinR2 NM_001037979 AGGTGACACTATAGAATACACTCCTGGAGAGAAGG GTACGACTCACTATAGGGACTGAATGCTGAGTGATACAT
IRS NM_017071 AGGTGACACTATAGAATAAGCTGGAGGAGTCTTCAT GTACGACTCACTATAGGGAAAGGGATCTTCGCTTT
Pik3 NM_133399 AGGTGACACTATAGAATACAAGGATCTGACTTATTTCC GTACGACTCACTATAGGGACTAACCATGCTGTTACCAA
LeptinR NM_012596 AGGTGACACTATAGAATACAAAGTCCAGGATGACAC GTACGACTCACTATAGGGACTTGGACAAACTCAGAATG
PPIA a NM_017101 AGGTGACACTATAGAATATTCTGTAGCTCAGGAGAGCA GTACGACTCACTATAGGGATTGAAGGGGAATGAGGAAAA
GAPDHa, b NM_017008 A GGTGACACTATAGAATAATGACTCTACCCACGGCAAG GTACGACTCACTATAGGGAAGCATCACCCCATTTGATGT
KanR c
a House Keeping gene, b Normalized gene, c Internal control
Reverse transcription (RT) and PCR were done according to manufacturer’s instructions; RT reaction was at 48 °C for 1 min; 37 °C for 5 min; 42 °C for 60 min; 95 °C
for 5 min, then hold at 4 °C, while PCR was as follows: initial denaturation at 95 °C for 10 min, followed by two-step cycles of 94 °C for 30 s and 55 °C for 30 s, end-
ing in a single extension cycle of 68 °C for 1 min
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Organ weight
Table 3 shows the organ weights index of the liver, kid-
ney, heart, brain, spleen and lung of the experimental
rats. The HFHC group showed significantly higher
weights index for the liver and kidney compared with
other groups (p < 0.05). Additionally, the high doses of
AL and AML showed lower liver weights index, which
were comparable with those of the STATIN group.
However, the weights index of the heart, spleen, kidney,
brain and lung were not significantly different between
the groups.
OGTT
The consumption of the HFHC diet significantly in-
creased insulin resistance biomarkers. An OGTT was
performed at the end of the 7th week of intervention
(Fig. 2), which showed that the HFHC group had signifi-
cantly higher average fasting blood glucose at baseline
(before administration of the glucose load) and subse-
quently thereafter. The AL and AML groups showed
percentage changes in dose dependent manner, from the
respective base lines.
Effects of C.nutans on serum insulin, glucose level,
HOMA-IR and adipokines secretion
Serum insulin levels decreased in a dose dependent
manner for both the AL and AML groups (p < 0.05)
(Table 4). The fasting blood glucose levels of all the
treated groups were lower in comparison with that of
the HFHC group, however, only the high and medium
doses of C.nutans showed significantly lower fasting
blood glucose compared with the HFHC group (p <
0.05). Furthermore, the AL (H), AL (M) and AML (H)
groups showed significantly improved insulin sensitivity
(HOMA-IR) in comparison with the HFHC group (p <
0.05) (Table 4).
There was significant elevation of RBP4 (Table 4) in
the HFHC, statin and low dose C.nutans treated groups,
while the other groups had lower levels (p < 0.05).
Table 2 The proximate analysis and selected minerals of the
leaf of Clinacanthus nutans
Nutritional value (% Dry weight) Leaf
Crude Carbohydrate 73.27 ± 3.14
Crude protein 5.16 ± 0.08
Crude fats 2.21 ± 0.66
Moisture 9.28 ± 0.40
Ash 10.0 ± 0.20
Total Energy (KJ/100 g) 1310.68 ± 2.09
Minerals (mg/100 g DW) Leaf
Sodium 6.78 ± 1.01
Potassium 1097.90 ± 6.93
Calcium 874.50 ± 31.25
Copper 0.26 ± 0.01
Values are expressed as percentage dry weight (% DW) for proximate analysis
whereas for mineral content was expressed as mg/100 g dry weight (DW). All
the values are means of three replicates and data is reported as mean ±
standard deviation (n = 3)
Fig. 1 Effects of Clinacanthus nutans on body weight changes in high fat and high cholesterol diet-fed Sprague–Dawley rats for 7 weeks. Values
are means ± SD, n = 7 rats/group. * p < 0.05 vs HFHC for each week according to Duncan’s multiple range test. NC, normal control group; HFHC,
high fat and high cholesterol group; STATIN, simvastatin (10 mg/kg) group; AL (H), high dose aqueous leaf extract (500 mg/kg/day/rat) group; AL
(M), medium dose aqueous leaf extract (250 mg/kg/day/rat) group; AL (L), low dose aqueous leaf extract (125 mg/kg/day/rat) group; AML (H),
high dose aqueous methanolic leaf extract (500 mg/kg/day/rat) group; AML (M), medium dose aqueous methanolic leaf extract (250 mg/kg/day/
rat) group; AML (L), low dose aqueous methanolic leaf extract (125 mg/kg/day/rat) group
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Table 3 Organ weights index of high fat and high cholesterol-fed experimental rats after 7 weeks
Organ index
Liver Kidney Heart Brain Spleen Lung
NC 0.026 ± 0.001a 0.007 ± 0.001a 0.003 ± 0.002a 0.005 ± 0.000a 0.003 ± 0.001a 0.006 ± 0.001a
HFHC 0.059 ± 0.002b 0.005 ± 0.000b 0.003 ± 0.001a 0.005 ± 0.001a 0.003 ± 0.001a 0.005 ± 0.000a
STATIN 0.042 ± 0.005c 0.006 ± 0.001a 0.003 ± 0.001a 0.006 ± 0.001a 0.003 ± 0.000a 0.006 ± 0.001a
AL (H) 0.043 ± 0.004c 0.007 ± 0.001a 0.003 ± 0.001a 0.005 ± 0.001a 0.003 ± 0.001a 0.006 ± 0.001a
AL (M) 0.045 ± 0.004c 0.006 ± 0.001a,b 0.003 ± 0.001a 0.006 ± 0.001a 0.003 ± 0.000a 0.006 ± 0.001a
AL (L) 0.049 ± 0.003c 0.006 ± 0.000a 0.003 ± 0.001a 0.005 ± 0.000a 0.003 ± 0.001a 0.006 ± 0.001a
MULTI (H) 0.049 ± 0.004c 0.007 ± 0.001a 0.003 ± 0.000a 0.003 ± 0.002a 0.004 ± 0.001a 0.007 ± 0.001a
AML (M) 0.053 ± 0.006c 0.006 ± 0.001a,b 0.003 ± 0.001a 0.005 ± 0.001a 0.003 ± 0.001a 0.005 ± 0.001a
AML (L) 0.045 ± 0.003c 0.005 ± 0.003a,b 0.002 ± 0.001a 0.005 ± 0.000a 0.003 ± 0.000a 0.005 ± 0.001a
Values are means ± SD, n = 7 rats/group. Different superscript letters in each column indicate statistical difference (p < 0.05) different according to Duncan’s
multiple range test. Groupings are the same as Fig. 1
A
B
Fig. 2 Effects of Clinacanthus nutans after 7 weeks of intervention on oral glucose tolerance test (a) and glucose area under the curve using
trapeziol rule (b) in high fat and high cholesterol diet-fed Sprague–Dawley rats. Bars and error bars represent means ± SD (n = 7/group). Bars with
different letters in each panel indicate statistical difference (p < 0.05). Groups are the same as Fig. 1
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HFHC feeding induced a marked decrease in the serum
adiponectin level compared with the NC group. In con-
trast, the statin, AL (L), AL (M) and AL (H) groups had
elevated adiponectin levels, and interestingly, the statin
and AL (H) groups showed markedly elevated adiponec-
tin levels (5-fold and 3-fold, respectively) in comparison
with the HFHC group (p < 0.01). Similarly, C.nutans
treated groups had a dose-dependent effect on the
serum leptin levels.
mRNA levels of insulin resistance-related genes
The expressions of hepatic insulin resistance-related
genes were determined to understand the effects of
C.nutans at the transcriptomic level. As shown in Fig. 3a,
the hepatic expression levels of insulin receptor sub-
strate (IRS) were significantly elevated in rats treated
with the AL(H), AML(H), AML(M) extracts compared
with the untreated control (HFHC) group. Remarkably,
rats treated with the AML (H) extract had the highest
expression level, approximately 2 fold compared with
the HFHC group (p < 0.01). A different trend was ob-
served for the hepatic phosphatidylinositol-3-kinase
(PI3K) expression level; only the high doses of both ex-
tracts of C.nutans showed significantly high expression
levels and were comparable to the NC group (p < 0.05).
In addition, after 7 weeks of intervention, selected
adipokine-related genes namely, adiponectin R and lep-
tin R hepatic expression levels were assayed, and the re-
sults mirrored those of the ELISA tests. The adiponectin
R2 expression level was suppressed in the HFHC group
compared with the other groups (p < 0.01). Supplemen-
tation with C.nutans extract attenuated the effects of the
HFHC diet on hepatic adiponectin R2 expression, espe-
cially at the higher doses (p < 0.01). On the other hand,
leptin receptor expression in the HFHC group was
significantly higher compared with the NC group (2
fold) (p < 0.01), while the treated rats showed signifi-
cantly elevated leptin receptor levels, with the C.nutans-
treated groups showing dose-dependent effects.
Phenolic composition
Eight phenolic acids were tested, including Cinnamic
acid, protocatechuic acid, Vanillic acid, Gallic acid, Caf-
feic acid, Ferulic acid, Chlorogenic acid and p-coumaric
acid (Table 5). As we have recently reported [20], in both
extracts, protocatechuic acid was detected to be the
major phenolic acid, followed by Chlorogenic acid and
trace amounts of Caffeic acid. However, p-Coumaric
acid, Gallic acid and Vanillic acid were not detected in
both of the tested extracts. Cinammic acid and Ferullic
acid was detected in trace amounts in the AML extract,
but not detected in the AL extract.
Discussion
The nutritional compositions of the leaf of C. nutans
showed high proportion of carbohydrate, with lower
amounts of ash, moisture, crude protein and crude fat.
Hence, the low moisture content of C. nutans is indica-
tive of its low susceptibility to microbial infection and
potential long shelf-life [21]. The low protein contents
may have been influenced by the use of 4.40 as the con-
version factor instead of the traditional 6.25, because the
latter was reported to overestimate for tropical plants or
herbs [22]. The crude fat content was the lowest nutri-
tional constituent, and may be advantageous as the cal-
oric values are relatively low, (around 300 kcal) with
added benefits for people suffering from overweight or
overweight-related disease such as insulin resistance.
The ash content is generally recognized as a measure of
quality for the assessment of the functional properties of
Table 4 Effects of Clinacanthus nutans extracts on serum insulin resistance biomarkers in high fat and high cholesterol-fed rats after
7 weeks of intervention
Groups Insulin resistance biomarkers
Insulin(ng/ml) Glucose(mmol/l) HUMAN-IR RBP4(ng/ml) Adiponectin(ng/ml) Leptin(ng/ml)
NC 1.23 ± 0.09a 4.42 ± 0.34a 5.12 ± 1.12a 25.00 ± 1.72a 88.76 ± 16.86a 7.02 ± 0.81a
HFHC 2.97 ± 0.12b 6.20 ± 0.22b 17.36 ± 3.11b 56.50 ± 1.96b 41.54 ± 02.41b 3.21 ± 1.12b
STATIN 2.54 ± 0.11c 5.45 ± 1.26b 13.05 ± 2.09b 54.10 ± 4.26b 203.63 ± 07.43c 8.35 ± 0.92a
AL (H) 1.54 ± 0.09d 4.95 ± 0.36a 7.19 ± 1.51a 30.00 ± 7.32a 134.25 ± 05.50d 12.00 ± 0.41c
AL (M) 1.92 ± 0.12e 5.38 ± 0.57a 9.73 ± 1.29c 35.20 ± 6.68a 83.25 ± 11.11a 8.13 ± 0.51a
AL (L) 2.34 ± 0.10f 5.83 ± 0.22b 12.79 ± 1.90b 47.30 ± 12.32b 63.15 ± 06.07a 5.86 ± 1.24a
MULTI (H) 1.82 ± 0.10e 5.27 ± 0.44a 9.05 ± 1.51c 32.50 ± 8.32a 82.90 ± 21.20a 13.01 ± 1.01c
MULTI (M) 2.51 ± 0.12f 5.44 ± 0.12c 12.87 ± 1.43b 45.20 ± 2.28c 52.06 ± 22.40a,b 8.59 ± 0.73a
MULTI (L) 2.83 ± 0.21g 5.75 ± 0.32 b, c 15.34 ± 1.12b 50.40 ± 1.07b 69.25 ± 15.87a,b 6.43 ± 0.92a
Values represent means ± SD (n = 7/group). Different superscript letters in each column indicate statistical difference (p < 0.05) according to Duncan’s multiple
range tests. Groupings are the same as Fig. 1
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Fig. 4 Proposed schematic diagram showing the effects of the leaf extracts of Clincanthus nutans on insulin resistance biomarkers
A B
C D
Fig. 3 Hepatic mRNA levels of Insulin receptor substrate (IRS) (a), Phosphatidylinositol 3-kinase (PI3K) (b), Adiponectin Receptor 2 (c) and leptin
Receptor (d) genes in high fat and high cholesterol diet-fed rats after 7 weeks of intervention. Bars and error bars represent means ± SD (n = 7/
group). Bars with different letters in each panel indicate statistical difference (p < 0.05). Groups are the same as Fig. 1
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foods [23]. C. nutans contained high levels of total ash,
up to 15.08 % DW, in the dried leaf. Similarly, there was
a high content of minerals such as K followed by Ca, Na
and Cu. The high content of K compared to Na reflects
a very low Na/K ratio, which is favourable from a nutri-
tional point of view, as diets with low Na/K ratio are as-
sociated with lower incidence of hypertension [24]. This
may explain the nitric oxide (NO)-dependent
hypotensive effect reported by Nwokocha et al. [25]. Cu
concentrations in the leaf were relatively low (0.26 mg/
100 g DW). Cu is an essential trace element needed only
in minute amounts by the human body for important
biochemical functions, however, as low as 10 mg per day
intake may cause toxic effect [26]. Ca was found to be
the second most abundant mineral element present in
this plant. Therefore, C. nutans can be considered an ap-
propriate dietary source of Ca to maintain the biological
role of nerve transmission, muscle contraction, glandular
secretion as well as mediating vascular contraction and
vasodilation [27].
It has been observed that the disorders induced by
high fat feeding resemble the human metabolic syn-
drome closely, with implications for the cardiovascular
health [28]. We observed significant increase in liver
weight in the HFHC group similar to the findings of
Padmaja et al. [29] who demonstrated that HFHC in ex-
perimental diets will cause lipid accumulation in some
organs, especially the liver. C. nutans attenuated the
HFHC induced changes without apparent toxicity to
other organs, as seen from the organ weights index in
Table 3. Moreover, P’ng et al. [30] demonstrated that C.
nutans was not toxic to the male rat liver and kidney at
concentrations of up to 1800 mg/kg.
Studies have shown that there is correlation between
hyperlipidemia and IR [31]. Measurements of fasting
plasma glucose and insulin are widely available, and their
use to calculate an index of IR (HOMA-IR) has gained
wide acceptance [32]. In this study, rats fed with the
HFHC diet alone showed significant worsening of IR,
while administration of C. nutans especially at higher
doses for 7 weeks caused a significant attenuation of the
HFHC-induced IR. In addition, these results suggest that
C. nutans might improve IR by normalizing the post-
prandial plasma glucose level as noted from the OGTT
data. OGTT is one of the most critical criteria for evalu-
ating the effectiveness of a particular compound in con-
trolling IR and plasma glucose [33]. In the HFHC group,
the elevated blood glucose levels remained high after
120 min, while in the AL and AML groups, there was
significant attenuation of the blood glucose increases.
Nevertheless, 120 min after glucose load, statin did not
show a significant reduction in glucose level compared
with the HFHC group. This study revealed that oral ad-
ministration of C. nutans significantly improved glucose
tolerance, which could be attributed to the potentiation
of the insulin effect of plasma by increasing the pancre-
atic secretion of insulin from existing b-cells, its release
from bound form or enhancements in its activity.
Cumulative researches have reported that high caloric
diets lead to an increase in adipose tissue [31]. Also, evi-
dence indicates that adipocytes, as the major cellular
component of white adipose tissue, contribute to IR via
adipocytokines. RBP4, adiponectin, leptin, IL-6 and
TNF-α are most widely reported in this context [34].
Circulating RBP4 levels positively correlate with the
degree of IR. Moreover, increased RBP4 levels are found
in subjects with obesity, diabetes and cardiovascular dis-
ease [35, 36]. Intriguingly, the results of higher doses of
the C .nutans-treated groups showed significantly lower
RBP4 compared with the HFHC group, but not the sta-
tin and low doses of both extracts. Furthermore, adipo-
nectin, believed to be produced mainly by mature
adipocytes and other organs to a smaller extent, is the
prototype of anti-inflammatory cytokines, and is de-
creased in obesity, and inversely correlated with IR, dys-
lipidemia, and atherosclerosis [35, 37]. In this study, the
statin group showed the most beneficial biofunction
followed by the AL- and AML-treated groups in dose-
dependent manner. Leptin is a hormone that regulates ap-
petite and adiposity. With the increase in adipose tissue
weight, serum leptin levels also tend to decrease due to in-
creases in lipid accumulation in various tissues of high fat
diet-fed animals [38]. Moreover, the increased leptin level
in serum of rats treated with C. nutans indicated that the
lower weight in the C.nutans-treated rats may have con-
tributed to this effect. The results indicate that C. nutans
can prevent disorders related to the metabolic syndrome.
To have insights into the mechanistic basis for the
regulation of the IR markers, the transcriptional
Table 5 Phenolic compositions of the extracts from the leaf of
Clinacanthus nutans
Individual phenolic content in C. nutans extracts (mg/g extract)
Phenolic Compound Aqueous leaf Aqueous methanol leaf
(AL) (AML)
Cinnamic acid ND 0.64 ± 0.01
Proto-Catechuic acid 33.29 ± 0.01a 33.28 ± 0.01a
Vanillic acid ND ND
Gallic acid ND ND
Caffeic acid 5.11 ± 0.04a 3.62 ± 0.04b
Ferulic acid ND 1.33 ± 0.02
Chlorogenic acid 22.84 ± 9.14a 33.38 ± 0.31b
p-coumaric ND ND
Data of phenolic compositions are means of three replicates and data are
reported as mean ± standard deviation (n = 3). Different superscript letters in
each row indicate statistical difference (p < 0.05) according to Duncan’s
multiple range test. ND = non detected
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regulation of genes involved in insulin signaling (IRS
and PI3K) and those of selected adipokines (Adiponectin
R2 and Leptin R) were evaluated. As can be recalled, any
defects in the insulin signaling cascade can cause IR [4,
5]. Insulin stimulates a signaling network and the signal-
ing axis of IRS and PI3K, which activates downstream
serine/threonine kinases that regulate most of the meta-
bolic actions of insulin, such as suppression of hepatic
glucose production and activation of glucose transport
in muscle and adipocyte [39]. This pathway is impaired
at multiple steps through alterations in the expression
levels and activities of the signaling molecules, en-
zymes, and transcription factors in IR caused by HFHC
diet [4, 5]. Thus, compounds that are able to regulate
these genes can be potentially beneficial for the man-
agement of IR-related diseases. As shown in Fig. 2 the
reduced expressions of IRS and PI3K due to prolonged
HFHC feeding were attenuated by C. nutans especially
the higher doses of the extracts. Furthermore, the
expressions of hepatic adiponectin R2 and leptin R
genes were also modulated by treatment with C.
nutans, in line with the changes observed in the serum
adiponectin and serum leptin levels (Table 4).
The attenuation of IR biomarkers may be due to the
presence of active constituents like proto-Catechuic acid,
Cholorogenic acid, Caffeic acid, Cinnamic acid and Feru-
lic acid in the C. nutans extracts. Phenolic compounds
are widely distributed in fruits and vegetables and are the
major class of antioxidants found in plant-derived foods
[40]. Proto-Catechuic acid was the major compound
detected in both extracts, and may have contributed sig-
nificantly to the biological activities of the plant. Scazzoc-
chio et al. [41] demonstrated that proto-Catechuic acid
possessed insulin-like effects. Chlorogenic acid may also
have contributed as seen from the superior bioactivity of
the AML extract with higher chlorogenic acid over the
AL extract, against body weight, lipid profile and insulin
resistance biomarkers. Moreover, Cholorogenic acid has
been shown to regulate glucose and lipid metabolism
[42]. Additionally, Cinnamic acid was detected in the
AML extract, but not the AL extract. Cinnamic acid and
Caffeic acid have been shown to improve glucose metab-
olism via modulating gluconeogenesis and glycogenesis in
insulin-resistant mouse hepatocyte model [43]. Ferulic
acid, on the other hand, was detected in trace amounts in
both the AL and AML extract, suggesting that it may
have contributed minimally to improved insulin resist-
ance biomarkers. In general, however, based on the pres-
ence of multiple phenolics in the extracts of C. nutans, it
is likely that synergism played a role in their overall bio-
activities. We recently hypothesized that extracts with a
lead compound and smaller amounts of other bioactive
compounds produced superior bioactivity likely due to
the synergistic effects of the multiple bioactives [44], and
the same effect may have contributed to the bioactivity of
the extracts used in this study. In aggregate, the data
showed that the HFHC diet promoted IR through modu-
lation of various indices, while C. nutans and simvastatin
attenuated the HFHC-induced changes, although C.
nutans produced better results than simvastatin. Based
on the findings, we proposed the mechanistic basis for
the attenuation of the HFHC-induced IR by C.nutans leaf
extracts as shown on Fig. 4.
Conclusions
In this study, we demonstrated that HFHC feeding will
induce IR (higher OGTT, HOMA-IR, lipid leptin, RBP4
and lipid profile, and lower adiponectin levels), partly
through transcriptional modulation of insulin signaling
genes. C. nutans, however is able to prevent IR by pre-
venting some of the transcriptional changes on insulin
signaling genes induced by the HFHC likely mediated
by multiple bioactive compounds including protocate-
chuic acid and chlorogenic acid. There is need to fur-
ther evaluate the potential use of C. nutans in the
management of IR in already established insulin-
resistant conditions especially in humans and also con-
firm bioactive compounds responsible for the effects
observed. In view of the growing interest in plant biore-
sources as potentially cost-effective and safer alterna-
tives to available drugs for managing chronic diseases,
this plant may potentially be a good source of func-
tional ingredients for managing metabolic disorders
like IR.
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